Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma

C. E. Ehrlich, Frederick Stehman, S. D. Williams

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)
Original languageEnglish
Title of host publicationProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

Fingerprint

Vinblastine
Bleomycin
Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ehrlich, C. E., Stehman, F., & Williams, S. D. (1982). Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. In Proceedings of the American Society of Clinical Oncology (Vol. Vol. 1)

Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. / Ehrlich, C. E.; Stehman, Frederick; Williams, S. D.

Proceedings of the American Society of Clinical Oncology. Vol. Vol. 1 1982.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ehrlich, CE, Stehman, F & Williams, SD 1982, Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. in Proceedings of the American Society of Clinical Oncology. vol. Vol. 1.
Ehrlich CE, Stehman F, Williams SD. Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. In Proceedings of the American Society of Clinical Oncology. Vol. Vol. 1. 1982
Ehrlich, C. E. ; Stehman, Frederick ; Williams, S. D. / Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma. Proceedings of the American Society of Clinical Oncology. Vol. Vol. 1 1982.
@inbook{ecf9f5c8881c4f7d898a7bfc99142e36,
title = "Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma",
author = "Ehrlich, {C. E.} and Frederick Stehman and Williams, {S. D.}",
year = "1982",
language = "English",
volume = "Vol. 1",
booktitle = "Proceedings of the American Society of Clinical Oncology",

}

TY - CHAP

T1 - Evaluation of vinblastine (VBL), bleomycin (BLEO), and cis-platin (CPDD) as second trial therapy in patients with recurrent ovarian carcinoma

AU - Ehrlich, C. E.

AU - Stehman, Frederick

AU - Williams, S. D.

PY - 1982

Y1 - 1982

UR - http://www.scopus.com/inward/record.url?scp=0020418036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020418036&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0020418036

VL - Vol. 1

BT - Proceedings of the American Society of Clinical Oncology

ER -